UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia

Leukemia & lymphoma, 2014-12, Vol.55 (12), p.2935-2937

2014

Volltextzugriff (PDF)

Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy

The Turkish journal of gastroenterology, 2014-12, Vol.25 Suppl 1 (1), p.233-233

2014

Volltextzugriff (PDF)

Two leptospirosis cases presented with fever, anemia, and hepatosplenomegaly

Medical journal of Bakirköy, 2017-01, p.107-109

2017

Volltextzugriff (PDF)

Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options

Turkish journal of haematology, 2014-12, Vol.31 (4), p.374-380

2014

Volltextzugriff (PDF)

Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1)

Turkish journal of haematology, 2014-06, Vol.31 (2), p.111-120

2014

Volltextzugriff (PDF)

Recurrent Monosomies Confirmed by Interphase FISH in Three Chronic Myeloid Leukemia Cases

Turkish journal of haematology, 2015-03, Vol.32 (1), p.82-84

2015

Volltextzugriff (PDF)

First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate

British journal of haematology, 2014-10, Vol.167 (1), p.139-141

2014

Volltextzugriff (PDF)

Bone marrow transplantation for Behçet’s disease: a case report and systematic review of the literature

Rheumatology (Oxford, England), 2014-06, Vol.53 (6), p.1136-1141

2014

Volltextzugriff (PDF)

Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion

Leukemia research, 2014-07, Vol.38 (7), p.781-787

2014

Volltextzugriff (PDF)

The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms

Turkish journal of haematology, 2012-09, Vol.29 (3), p.242-247

2012

Volltextzugriff (PDF)

Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia

Journal of clinical pathology, 2016-09, Vol.69 (9), p.810-816

2016

Volltextzugriff (PDF)

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

The lancet oncology, 2019-06, Vol.20 (6), p.781-794

2019

Volltextzugriff (PDF)

Breast schwannoma in a patient with diffuse large B-cell lymphoma: a case report

Journal of medical case reports, 2012-12, Vol.6 (1), p.423-423, Article 423

2012

Volltextzugriff (PDF)

Synchronous Detection of Hairy Cell Leukemia and HIV-Negative Kaposi’s Sarcoma of the Lymph Node: A Diagnostic Challenge and a Rare Coincidence

Case reports in oncology, 2011-09, Vol.4 (3), p.439-444

2011

Volltextzugriff (PDF)

Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience

Balkan medical journal, 2018-01, Vol.35 (6), p.417-421

2018

Volltextzugriff (PDF)

Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed/Refractory to Immunomodulatory Drugs and Proteasome Inhibitors

Turkish journal of haematology, 2017-08, Vol.34 (3), p.233-238

2017

Volltextzugriff (PDF)

Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemia

Blood, 2015-12, Vol.126 (23), p.2783-2783

2015

Volltextzugriff (PDF)

Real-Life Data and a Single Center Experience on Dasatinib-Induced Pulmonary Arterial Hypertension in Patients with Philadelphia Chromosome-Positive Leukemias

Blood, 2015-12, Vol.126 (23), p.4037-4037

2015

Volltextzugriff (PDF)

Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience

Turkish journal of haematology, 2017-12, Vol.34 (4), p.291-299

2017

Volltextzugriff (PDF)

The Prognostic Value of Serum APRIL Levels in Patients with Chronic Lymphocytic Leukemia

Blood, 2014-12, Vol.124 (21), p.5648-5648

2014

Volltextzugriff (PDF)

Next-Generation Sequencing Of The BCR-ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance

Blood, 2013-11, Vol.122 (21), p.384-384

2013

Volltextzugriff (PDF)

Ten-Year Follow-up Data of Diffuse Large B-Cell Lymphoma Patients: Single Center Experience

Blood, 2011-11, Vol.118 (21), p.5223-5223

2011

Volltextzugriff (PDF)

CLLU1 Gene Expression Level As a Prognostic Parameter in Patients with Chronic Lymphocytic Leukemia

Blood, 2011-11, Vol.118 (21), p.4603-4603

2011

Volltextzugriff (PDF)

Imatinib for Chronic Myeloid Leukemia Patients: A Single Institution Experience

Blood, 2011-11, Vol.118 (21), p.4429-4429

2011

Volltextzugriff (PDF)

Multidrug Resistance Gene (MDR1) C3435T Polymorphism and Imatinib Response in Patients with Chronic Myeloid Leukemia

Blood, 2011-11, Vol.118 (21), p.1692-1692

2011

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(70)
Berichte
(3)

Sprache

Englisch
(73)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(34)
Science & Technology
(34)
Hematology
(25)
Humans
(22)
Female
(17)
Male
(16)
Middle Aged
(15)
Adult
(13)
Aged
(13)
Oncology
(13)
Aged, 80 And Over
(10)
Retrospective Studies
(10)
Treatment Outcome
(9)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(8)
Chronic Myeloid Leukemia
(7)
Protein Kinase Inhibitors - Therapeutic Use
(6)
Adolescent
(5)
Antineoplastic Agents - Therapeutic Use
(5)
General & Internal Medicine
(5)
Leukemia
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia

Acute colitis presenting with hematochezia in a patient with chronic myeloid leukemia during dasatinib therapy

Two leptospirosis cases presented with fever, anemia, and hepatosplenomegaly

Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options

Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1)

Recurrent Monosomies Confirmed by Interphase FISH in Three Chronic Myeloid Leukemia Cases

First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate

Bone marrow transplantation for Behçet’s disease: a case report and systematic review of the literature

Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion

The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms

Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Breast schwannoma in a patient with diffuse large B-cell lymphoma: a case report

Synchronous Detection of Hairy Cell Leukemia and HIV-Negative Kaposi’s Sarcoma of the Lymph Node: A Diagnostic Challenge and a Rare Coincidence

Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single-Institution Experience

Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed/Refractory to Immunomodulatory Drugs and Proteasome Inhibitors

Imatinib Mesylate Reduces Bone Marrow Fibrosis and Overwhelms the Adverse Prognostic Impact of Reticulin Formation in Patients with Chronic Myeloid Leukemia

Real-Life Data and a Single Center Experience on Dasatinib-Induced Pulmonary Arterial Hypertension in Patients with Philadelphia Chromosome-Positive Leukemias

Retrospective Evaluation of Hairy Cell Leukemia Patients Treated with Three Different First-Line Treatment Modalities in the Last Two Decades: A Single-Center Experience

The Prognostic Value of Serum APRIL Levels in Patients with Chronic Lymphocytic Leukemia

Next-Generation Sequencing Of The BCR-ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance

Ten-Year Follow-up Data of Diffuse Large B-Cell Lymphoma Patients: Single Center Experience

CLLU1 Gene Expression Level As a Prognostic Parameter in Patients with Chronic Lymphocytic Leukemia

Imatinib for Chronic Myeloid Leukemia Patients: A Single Institution Experience

Multidrug Resistance Gene (MDR1) C3435T Polymorphism and Imatinib Response in Patients with Chronic Myeloid Leukemia

Suchergebnisse filtern